MariMed Inc. (OTCMKTS:MRMD - Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totalling 125,500 shares, an increase of 302.2% from the September 30th total of 31,200 shares. Based on an average daily volume of 853,800 shares, the days-to-cover ratio is currently 0.1 days.
Wall Street Analyst Weigh In
Separately, Ventum Cap Mkts upgraded MariMed to a "strong-buy" rating in a research note on Thursday, August 8th.
Read Our Latest Report on MRMD
MariMed Price Performance
Shares of OTCMKTS:MRMD remained flat at $0.17 on Friday. 182,783 shares of the company's stock were exchanged, compared to its average volume of 450,092. MariMed has a 52 week low of $0.14 and a 52 week high of $0.39. The business has a fifty day simple moving average of $0.17 and a 200-day simple moving average of $0.20. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.55 and a quick ratio of 0.73. The company has a market cap of $62.65 million, a price-to-earnings ratio of -4.13 and a beta of 2.80.
About MariMed
(
Get Free Report)
MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MariMed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MariMed wasn't on the list.
While MariMed currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
